06:24 AM EDT, 05/07/2025 (MT Newswires) -- BeiGene ( ONC ) reported Q1 adjusted earnings Wednesday of $1.22 per diluted American depositary share, swinging from an adjusted loss of $1.40 a year earlier.

Comparable analyst estimates were not readily available.

Revenue for the quarter ended March 31 was $1.12 billion, up from $751.7 million a year earlier.

Analysts surveyed by FactSet expected $1.13 billion.

For 2025, the biotech company continues to expect revenue of $4.9 billion to $5.3 billion.

Analysts polled by FactSet expect $5.07 billion.

Shares of the company were down more than 5% in recent premarket activity.

Price: 229.00, Change: -12.75, Percent Change: -5.27